FYZAMAB
Live / Registered — Registered (as of 21 Mar 2023)
What this means for you
Registered since 21 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90145045
- Registration number
- 7002903
- Mark type
- Stylized text
- Filed
- 28 Aug 2020
- Published for opposition
- 03 Jan 2023
- Registered
- 21 Mar 2023
- Attorney of record
- Bruce S. Londa
Goods and services
- Class 042 — Scientific and technological services: Biomedical research services; research and development in the field of biotechnology; Scientific and technological services, namely, analysis in the field of molecular biology; pharmaceutical research and development services; research relating to molecular sciences; research relating to medicine; medical research
Owner
- Fyzant Pharma Pte. Ltd., Singapore, SG
- Fyzant Pharma Pte. Ltd., Singapore, SG
- Fyzant Pharma Pte. Ltd., Singapore, SG
Prosecution history
- 21 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 03 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jan 2023 — PUBLISHED FOR OPPOSITION
- 14 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Nov 2022 — CASE RETURNED TO EXAMINATION
- 23 Nov 2022 — NOTICE OF ALLOWANCE CANCELLED
- 22 Nov 2022 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 22 Nov 2022 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 21 Nov 2022 — ASSIGNED TO PETITION STAFF
- 05 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2022 — SOU EXTENSION 3 GRANTED
- 03 Nov 2022 — SOU EXTENSION 3 FILED
- 03 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2022 — TEAS PETITION TO AMEND BASIS RECEIVED